Docket

39007

Millennium Pharmaceuticals Inc., et al. v. Teva Canada Limited, et al.

(Federal Court) (Civil) (By Leave)

(Sealing order) (Certain information not available to the public)

Judgments on applications for leave to appeal are rendered by the Court, but are not necessarily unanimous.

Proceedings
Date Proceeding Filed By
(if applicable)
2020-08-07 Close file on Leave
2020-05-08 Copy of formal judgment sent to Registrar of the Court of Appeal and all parties
2020-05-08 Judgment on leave sent to the parties
2020-05-07 Judgment of the Court on the application for leave to appeal, The application for leave to appeal from the judgment of the Federal Court of Appeal, Number A-301-18, 2019 FCA 273, dated November 4, 2019, is dismissed with costs.
Dismissed, with costs
2020-04-06 All materials on application for leave submitted to the Judges, for consideration by the Court
2020-02-13 Certificate (on limitations to public access), (Letter Form), 23B - Reply Millennium Pharmaceuticals Inc.
2020-02-13 Applicant's reply to respondent's argument, (Book Form), Completed on: 2020-02-13 Millennium Pharmaceuticals Inc.
2020-02-03 Certificate (on limitations to public access), (Letter Form), 23B Teva Canada Limited
2020-02-03 Certificate (on limitations to public access), (Letter Form), 23A Teva Canada Limited
2020-02-03 Notice of name, (Letter Form) Teva Canada Limited
2020-02-03 Respondent's response on the application for leave to appeal, (Book Form), SEALED / RESTRICTED, Completed on: 2020-03-20 Teva Canada Limited
2020-01-09 Letter acknowledging receipt of a complete application for leave to appeal, FILE OPENED 01/09/20
2020-01-03 Book of authorities, (Book Form), Completed on: 2020-01-03 Millennium Pharmaceuticals Inc.
2020-01-03 Certificate (on limitations to public access), (Letter Form), 23B Millennium Pharmaceuticals Inc.
2020-01-03 Certificate (on limitations to public access), (Letter Form), 23A Millennium Pharmaceuticals Inc.
2020-01-03 Notice of name, (Letter Form) Millennium Pharmaceuticals Inc.
2020-01-03 Application for leave to appeal, (Book Form), Tab 3 : Unredacted decision (2018 FC 754) filed separately on 01/03/20 - SEALED, Completed on: 2020-01-06 Millennium Pharmaceuticals Inc.